Other-Net, Expense (Income)

6 Months Ended

Jun. 30, 2013

Nonoperating Income (Expense) [Abstract]

Other - Net, Expense (Income) [Text Block]

Note 14: Other—Net, (Income) Expense

Other–net, (income) expense consisted of the following:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2013			2012			2013			2012
Income related to transfer of exenatide commercial rights (Note 4)	$	—		$	—		$	(495.4	)	$	—
Interest expense	40.3			43.0			80.6			88.3
Interest income	(29.7		)	(27.2		)	(53.3		)	(53.3		)
Other	(22.5		)	0.7			(73.0		)	27.5
Other—net, (income) expense	$	(11.9	)	$	16.5		$	(541.1	)	$	62.5

The increase in other—net, (income) expense for the first six months is primarily related to income recognized from the transfer to Amylin of exenatide commercial rights in all markets outside the United States during the first quarter of 2013. See Note 4 for additional information.